Status:
ACTIVE_NOT_RECRUITING
Effect of Theronomic Ova-All Care on Biomarkers of Ovarian Health in Adult Female With Polycystic Ovarian Syndrome
Lead Sponsor:
Wellizen Australia
Conditions:
Polycystic Ovarian Syndrome (PCOS)
Eligibility:
FEMALE
18-40 years
Phase:
PHASE2
Brief Summary
Theronomic Ova-All Care is a tribiotic health product aimed at improving ovarian health in people with polycystic ovarian syndrome (PCOS). In this study, a total of 16 participants with PCOS diagnosed...
Eligibility Criteria
Inclusion
- Inclusion criteria
- Women aged 18-40 years
- Previous diagnosis of PCOS by a gynaecologist
- Able to take body temperature every day for 12 weeks
- Able to attend the testing centre every 4 weeks
- Able to complete online questionnaires
- Exclusion criteria
- Pregnancy, lactation;
- Uterine amenorrhea (such as intrauterine adhesions)
- Thyroid disease or hyperprolactinemia
- Liver and kidney dysfunction, autoimmune diseases (such as systemic lupus erythematosus), malignant tumors, mental illness
- Use of contraceptives, hormone replacement therapy (HRT), immunosuppressants and other drugs that affect ovarian function in the past 3 months.
- Smokers (\>5 cigarettes per day), alcoholics;
- Unable to cooperate with follow-up or refuse to sign informed consent.
Exclusion
Key Trial Info
Start Date :
May 9 2025
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2025
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT06963840
Start Date
May 9 2025
End Date
August 1 2025
Last Update
August 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pony Testing Centre
Suzhou, Jiangsu, China